Blood GFAP levels are correlated with the clinical severity and extent of intracranial pathology in spinal cord disorders, acute CNS trauma, ischemia, neurodegenerative diseases, malignant brain tumors, and cerebrovascular events [49,82,87,88]. The gene discussed is GFAP; the disease is neurodegenerative disease.